Key result
Dobutamine infusion linked to biopsy-proven eosinophilic myocarditis reversible with drug discontinuation and corticosteroids.
Why the study?
Eosinophilic myocarditis is a rare form of myocarditis often triggered by drug hypersensitivity reactions.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Clinicians should consider drug-induced eosinophilic myocarditis in patients with refractory cardiogenic shock receiving dobutamine.
Eosinophilic myocarditis (EM) is a rare form of myocarditis that is often triggered by drug hypersensitivity reactions. We describe the case of a 55-year-old man who presented with cardiogenic shock that rapidly progressed despite dual inotropic therapy, ultimately requiring left ventricular assist device implantation. A left ventricular apical core biopsy demonstrated eosinophilic infiltration consistent with EM. After comprehensive evaluation of the possible etiologies, dobutamine was identified as the most likely offending agent. Following discontinuation of dobutamine and initiation of corticosteroid therapy, ventricular function and hemodynamics improved, supporting a diagnosis of dobutamine-associated EM. Clinicians should consider drug-induced EM in patients with refractory cardiogenic shock receiving dobutamine. Alternative inotropic agents such as milrinone or epinephrine should be considered.
No takes yet. Share an insight, caveat, or question.
Aljudaibi et al. (2026) conducted a case report in Cardiogenic shock and eosinophilic myocarditis (n=1). Dobutamine was evaluated. Dobutamine infusion in a patient with cardiogenic shock was associated with the development of biopsy-proven eosinophilic myocarditis, which improved after drug discontinuation and corticosteroid therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: